Ally Bridge Group (Ny) LLC Xenon Pharmaceuticals Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $107 Million
- Q2 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 169,369 shares of XENE stock, worth $6.66 Million. This represents 6.19% of its overall portfolio holdings.
Number of Shares
169,369
Previous 309,369
45.25%
Holding current value
$6.66 Million
Previous $13.3 Million
50.42%
% of portfolio
6.19%
Previous 11.72%
Shares
4 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
69.6MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$223 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$174 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$151 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$108 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$106 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.45B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...